An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2019
Price : $35 *
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2018 Status changed from not yet recruiting to recruiting.
- 09 Oct 2018 New trial record